RDEA 806
RDEA 806 is an orally effective non-nucleoside reverse transcriptase (NNRT) inhibitor that exhibits potent in vitro inhibitory activity against wild-type HIV-1 (EC50 = 1.7 ng/mL) and NNRTI-resistant HIV-1. RDEA 806 is a prodrug of Lesinurad (HY-15258) and functions as a URAT1 inhibitor, exerting a uric acid-lowering effect. RDEA 806 rapidly reduces HIV-1 RNA viral load in vivo. RDEA 806 has a favorable biosafety profile. RDEA 806 can be used for research related to HIV-1 infection.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 878670-61-2
- Formule: C24H18BrClN4O3S
- Masse moléculaire:557.85
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Essai clinique
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 878670-61-2
-
Masse moléculaire 557.85
-
Formule C24H18BrClN4O3S
-
SMILES
ClC(C=C(C(O)=O)C=C1)=C1NC(CSC2=NN=C(Br)N2C3=CC=C(C4CC4)C5=C3C=CC=C5)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Moyle G, et al. Phase 2a randomized controlled trial of short-term activity, safety, and pharmacokinetics of a novel nonnucleoside reverse transcriptase inhibitor, RDEA806, in HIV-1-positive, antiretroviral-naive subjects. Antimicrobial agents and chemotherapy. 2010 Aug;54(8):3170-8. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- RDEA 806
- 878670-61-2
- RDEA806
- RDEA-806
- HIV
- Reverse Transcriptase
- URAT1
- Human immunodeficiency virus
- Urate transporter 1
- SLC22A12
- HIV-1 RNA viral load
- HIV-1-infected subjects
- HIV-1 infection
- oral agent
- NNRTI-resistant mutants
- NNRTI-resistant
- NNRTI
- wild-type
- antiretroviral-na?ve
- HIV-1 reverse transcriptase
- Inhibitor
- inhibitor
- inhibit